Oak Street Health (OSH) Stock Forecast, Price & News

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Oak Street Health in the last twelve months. There are currently 1 sell rating, 14 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" OSH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OSH, but not buy additional shares or sell existing shares.
View OSH analyst ratings or view top-rated stocks.

17 brokers have issued 1-year target prices for Oak Street Health's shares. Their OSH share price forecasts range from $18.00 to $39.00. On average, they predict the company's share price to reach $33.27 in the next twelve months.
View analysts price targets for OSH or view top-rated stocks among Wall Street analysts.

The company is scheduled to release its next quarterly earnings announcement on Monday, July 31st 2023.
View our OSH earnings forecast.

Oak Street Health, Inc. (NYSE:OSH) released its earnings results on Tuesday, February, 28th. The company reported ($0.56) EPS for the quarter, beating analysts' consensus estimates of ($0.58) by $0.02. The company had revenue of $577.70 million for the quarter, compared to analyst estimates of $571.26 million. The company's revenue was up 46.6% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.62) EPS.

ETFs with the largest weight of Oak Street Health (NYSE:OSH) stock in their portfolio include IQ Merger Arbitrage ETF (MNA), AltShares Merger Arbitrage ETF (ARB), ProShares Merger ETF (MRGR), SPDR S&P Health Care Services ETF (XHS), Renaissance IPO ETF (IPO), AltShares Event-Driven ET (EVNT), iShares U.S. Healthcare Providers ETF (IHF) and Fidelity Growth Opportunities ETF (FGRO).

17 employees have rated Oak Street Health Chief Executive Officer Peter Botten on Glassdoor.com. Peter Botten has an approval rating of 71% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Oak Street Health investors own include Alibaba Group (BABA), Tesla (TSLA), Adobe (ADBE), NVIDIA (NVDA), Okta (OKTA), Zoom Video Communications (ZM), Autodesk (ADSK), Boeing (BA), Lockheed Martin (LMT) and Micron Technology (MU).

(OSH) raised $250 million in an initial public offering (IPO) on Thursday, August 6th 2020. The company issued 15,600,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan, Goldman Sachs and Morgan Stanley acted as the underwriters for the IPO and William Blair, Piper Sandler, Baird and SunTrust Robinson Humphrey were co-managers.

Oak Street Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "OSH."

Oak Street Health's stock is owned by many different institutional and retail investors. Top institutional investors include Farallon Capital Management LLC (1.85%), Route One Investment Company L.P. (0.79%), Geode Capital Management LLC (0.66%), Davidson Kempner Capital Management LP (0.65%), Schonfeld Strategic Advisors LLC (0.60%) and Glazer Capital LLC (0.54%). Insiders that own company stock include Brian Clem, General Atlantic Llc, Geoffrey M Price, Geoffrey M Price, Griffin Myers, Kim Keck, Michael Robert Martin, Michael T Pykosz, Michael T Pykosz, Newlight Partners Lp, Robert Guenthner, Shawn Henry and Timothy M Cook.
View institutional ownership trends.

Shares of OSH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

Oak Street Health (NYSE:OSH) has a market capitalization of $0.00 and generates $2.16 billion in revenue each year. The company earns $-509,200,000.00 in net income (profit) each year or ($2.21) on an earnings per share basis.

The company employs 6,000 workers across the globe.

Oak Street Health's mailing address is 30 W. MONROE ST. STE. 1200, CHICAGO IL, 60603. The official website for the company is www.oakstreethealth.com. The company can be reached via phone at 844-871-5650 or via email at investors@oakstreethealth.com.